Malaria still kills some 0.5-2.5 million people per year in the tropics. Resistance to the cheap, most commonly used antimalarials continues to spread alarmingly and could outpace drug development. The artemisinin derivatives have had an important clinical impact both on the treatment of resistant falciparum malaria and on the incidence of disease in low-transmission areas. A few promising new antimalarials are being tested clinically but there is an imperative need for cheap, well-tolerated ...Expand abstract
- Publisher copy:
- Copyright date:
Malaria: new developments in treatment and prevention.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record